Andreas Kupsch
Overview
Explore the profile of Andreas Kupsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
6293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Haumesser J, Beck M, Pellegrini F, Kuhn J, Neumann W, Altschuler J, et al.
Exp Neurol
. 2020 Nov;
335:113513.
PMID: 33148526
Excessive beta activity has been shown in local field potential recordings from the cortico-basal ganglia loop of Parkinson's disease patients and in its various animal models. Recent evidence suggests that...
12.
Magkos S, Kupsch A, Bruno G
Rev Sci Instrum
. 2020 Nov;
91(10):103107.
PMID: 33138560
X-ray computed tomography has many applications in materials science and non-destructive testing. While the standard filtered back-projection reconstruction of the radiographic datasets is fast and simple, it typically fails in...
13.
Al-Falahat A, Kupsch A, Hentschel M, Lange A, Kardjilov N, Markotter H, et al.
Rev Sci Instrum
. 2020 Jan;
90(12):125108.
PMID: 31893786
In various kinds of radiography, deficient transmission imaging may occur due to backlighting inside the detector itself arising from light or radiation scattering. The related intensity mismatches barely disturb the...
14.
Galazky I, Zaehle T, Sweeney-Reed C, Neumann J, Heinze H, Voges J, et al.
Clin Neurophysiol
. 2019 Dec;
131(2):414-419.
PMID: 31877491
Objective: The pedunculopontine nucleus (PPN) has been proposed as a new deep brain stimulation (DBS) target for the treatment in idiopathic Parkinson's syndrome (IPS) and progressive supranuclear palsy (PSP). In...
15.
Buentjen L, Kupsch A, Galazky I, Frantsev R, Heinze H, Voges J, et al.
J Neuroeng Rehabil
. 2019 Jun;
16(1):72.
PMID: 31186029
Background: Central drop foot is a common problem in patients with stroke or multiple sclerosis (MS). For decades, it has been treated with orthotic devices, keeping the ankle in a...
16.
Panther P, Kuehne M, Voges J, Nullmeier S, Kaufmann J, Hausmann J, et al.
BMC Neurosci
. 2019 May;
20(1):20.
PMID: 31035935
Background: Prepulse inhibition (PPI) of the acoustic startle response, a measurement of sensorimotor gaiting, is modulated by monoaminergic, presumably dopaminergic neurotransmission. Disturbances of the dopaminergic system can cause deficient PPI...
17.
Schuepbach W, Tonder L, Schnitzler A, Krack P, Rau J, Hartmann A, et al.
Neurology
. 2019 Feb;
92(10):e1109-e1120.
PMID: 30737338
Objective: To investigate predictors for improvement of disease-specific quality of life (QOL) after deep brain stimulation (DBS) of the subthalamic nucleus (STN) for Parkinson disease (PD) with early motor complications....
18.
Brucke C, Horn A, Huppke P, Kupsch A, Schneider G, Kuhn A
Mov Disord Clin Pract
. 2019 Feb;
2(1):76-78.
PMID: 30713884
No abstract available.
19.
Gruber D, Calmbach L, Kuhn A, Krause P, Kopp U, Schneider G, et al.
J Neural Transm (Vienna)
. 2019 Jan;
126(3):309-318.
PMID: 30684055
Normal cognition is an established selection criteria for subthalamic (STN) deep brain stimulation (DBS) in Parkinson's disease (PD), while concern has been raised as to aggravated cognitive decline in PD...
20.
Krug H, Krause P, Kupsch A, Kuhn A
Mov Disord Clin Pract
. 2018 Oct;
2(2):187-189.
PMID: 30363903
Local injections of botulinum toxin type A (BoNT/A) are safe and efficacious to treat focal and segmental dystonia. However, there are no adequate studies in humans regarding the safety of...